Department of Healthcare Economics

• Considering Alpha-1 Testing
• Newly Diagnosed with Alpha-1
• Living With Alpha-1

Do you have a question about reimbursement for ARALAST?

The Department of Healthcare Economics can help you find answers.

Baxter's Department of Healthcare Economics has expertise in assisting healthcare providers, patients, and payors with a variety of economic, insurance, and reimbursement-related issues.

Our Department of Healthcare Economics:

• Provides coverage, support, and assistance with challenging issues
• Coordinates patient assistance programs
• Offers patient education programs and advocacy for insurance-related concerns
• Facilitates gathering technical and clinical information for medical professionals
• Analyzes and disseminates healthcare economics information to customers upon request

These services are available to Alpha-1 patients at no charge. Call the Department of Healthcare Economics (1-800-968-9937) for more information.

Do you belong to an Alpha-1 support group? Invite an HCE representative to speak at a meeting. Our HCE representatives can help your group understand the maze of insurance issues.

To request an HCE guest speaker contact us.

ARALAST [Alpha₁-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A₁-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A₁-PI deficiency has not been established.

Please review the Important Safety Information and the Full Prescribing Information